| [1] Hannon G J. RNA interference. Nature, 2002, 418(6894):244-251.
[2] Huang B, Zhang R. Regulatory non-coding RNAs:revolutionizing the RNA world. Molecular Biology Reports, 2014, 41(6):3915-3923.
[3] Dong P, Yu F, Fan X, et al. Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells. Molecular and Cellular Biochemistry, 2010, 344(1-2):195-202.
[4] Gehrau R, Mas V, Villamil F, et al. MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. American Journal of Transplantation, 2013, 13(3):729-737.
[5] Ohtani M, Takebayashi A, Hiroyama R, et al. Cell dedifferentiation and organogenesis in vitro require more snRNA than does seedling development in Arabidopsis thaliana. Journal of Plant Research, 2015, 128(3):371-380.
[6] Hutten S, Chachami G, Winter U, et al. A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA transcription mediated by RNA polymerase Ⅱ. Journal of Cell Science, 2014, 127(5):1065-1078.
[7] Matzke M A, Mosher R A. RNA-directed DNA methylation:an epigenetic pathway of increasing complexity. Nature Reviews Genetics, 2014, 15(6):394-408.
[8] Porrua O, Libri D. Transcription termination and the control of the transcriptome:why, where and how to stop. Nature Reviews Molecular Cell Biology, 2015, 16(3):190-202.
[9] Lam M T, Li W, Rosenfeld M G, et al. Enhancer RNAs and regulated transcriptional programs. Trends in Biochemical Sciences, 2014, 39(4):170-182.
[10] Vance K W, Ponting C P. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends in Genetics, 2014, 30(8):348-355.
[11] Natoli G, Andrau J C. Noncoding transcription at enhancers:general principles and functional models. Annual Review of Genetics, 2012, 46(7):1-19.
[12] Lee J T. Epigenetic regulation by long noncoding RNAs. Science, 2012, 338(6113):1435-1439.
[13] Guttman M, Rinn J L. Modular regulatory principles of large non-coding RNAs. Nature, 2012, 482(7385):339-346.
[14] Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs. Molecular Cell, 2011, 43(6):904-914.
[15] Rinn J L, Chang H Y. Genome regulation by long noncoding RNAs. Annual Review of Biochemistry, 2012, 81(7):145-166.
[16] Ulitsky I, Bartel D P. lincRNAs:genomics, evolution, and mechanisms. Cell, 2013, 154(1):26-46.
[17] Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 2009, 458(7235):223-227.
[18] Qiu M T, Hu J W, Yin R, et al. Long noncoding RNA:an emerging paradigm of cancer research. Tumor Biology, 2013, 34(2):613-620.
[19] Birney E, Stamatoyannopoulos J A, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 2007, 447(7146):799-816.
[20] Djebali S, Davis C A, Merkel A, et al. Landscape of transcription in human cells. Nature, 2012, 489(7414):101-108.
[21] Danko C G, Hah N, Luo X, et al. Signaling pathways differentially affect RNA polymerase Ⅱ initiation, pausing, and elongation rate in cells. Molecular Cell, 2013, 50(2):212-222.
[22] Conley A B, Miller W J, Jordan I K. Human cis natural antisense transcripts initiated by transposable elements. Trends in Genetics, 2008, 24(2):53-56.
[23] Dinger M E, Amaral P P, Mercer T R, et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Research, 2008, 18(9):1433-1445.
[24] Ponting C P, Oliver P L, Reik W. Evolution and functions of long noncoding RNAs. Cell, 2009, 136(4):629-641.
[25] Ramskold D, Wang E T, Burge C B, et al. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol, 2009, 5(12):e1000598.
[26] Hu X, Feng Y, Zhang D, et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell, 2014, 26(3):344-357.
[27] Mikkelsen T S, Ku M, Jaffe D B, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 2007, 448(7153):553-560.
[28] Sánchez Y, Segura V, Marín-Béjar O, et al.Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nature Communications, 2014, 5(12):1-13.
[29] Zhang Q, Chen C Y, Yedavalli V S, et al. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio, 2013, 4(1):e00596-00512.
[30] Zhao W, Mu Y, Ma L, et al.Systematic identification and characterization of long intergenic non-coding RNAs in fetal porcine skeletal muscle development. Scientific Reports, 2015, 5:1-8.
[31] Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs:analysis of their gene structure, evolution, and expression. Genome Research, 2012, 22(9):1775-1789.
[32] Han L, Zhang K, Shi Z, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. International Journal of Oncology, 2012, 40(6):2004-2012.
[33] Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & Development, 2011, 25(18):1915-1927.
[34] Liu X, Sun M, Nie F, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer, 2014, 13(1):92.
[35] Wang L, Zhao Y, Bao X, et al. LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Research, 2015, 25(3):335-350.
[36] Giannakakis A, Zhang J, Jenjaroenpun P, et al.Contrasting expression patterns of coding and noncoding parts of the human genome upon oxidative stress. Scientific Reports, 2015, 5:1-16.
[37] Kim D H, Marinov G K, Pepke S, et al. Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. Cell Stem Cell, 2015, 16(1):88-101.
[38] van Heesch S, van Iterson M, Jacobi J, et al.Extensive localization of long noncoding RNAs to the cytosol and mono-and polyribosomal complexes. Genome Biol, 2014, 15(1):1-12.
[39] Gonzalez I, Munita R, Agirre E, et al. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nature Structural & Molecular Biology, 2015, 22(5):370-376.
[40] Léveillé N, Melo C A, Rooijers K, et al.Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nature Communications, 2015, 6:1-12.
[41] Ørom U, Derrien T, Guigo R, et al. Long noncoding RNAs as enhancers of gene expression. Cold Spring Harbor Symposia on Quantitative Biology, 2011, 75(58):325-331.
[42] van Dijk M, Visser A, Buabeng K M, et al. Mutations within the LINC-HELLP non-coding RNA differentially bind ribosomal and RNA splicing complexes and negatively affect trophoblast differentiation. Human Molecular Genetics, 2015, 24(19):5475-5485.
[43] Han P, Li W, Lin C H, et al.A long noncoding RNA protects the heart from pathological hypertrophy. Nature, 2014,514(7520):102-106.
[44] Yan L, Zhou J, Gao Y, et al.Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene, 2014, 34(23):3076-3084.
[45] Li H J, Li X, Pang H, et al.Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer. Japanese Journal of Clinical Oncology, 2015,45(11):1055-1063.
[46] Wang K, Sun T, Li N, et al.MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361.PLoS Genetics, 2014, 10(7):1-12.
[47] Wang F, Ying H, He B, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget, 2015, 6(10):7899-7917.
[48] Gong C, Maquat L E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3[prime] UTRs via Alu elements. Nature, 2011, 470(7333):284-288.
[49] Wilusz J E. Long noncoding RNAs:re-writing dogmas of RNA processing and stability. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 2015, 1859(2016):128-138.
[50] Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature, 2013, 498(7455):516-520.
[51] Kim T, Cui R, Jeon Y J, et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proceedings of the National Academy of Sciences, 2014, 111(11):4173-4178.
[52] Lai F, Orom U A, Cesaroni M, et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature, 2013, 494(7438):497-501.
[53] Mathiyalagan P, Keating S T, Du X J, et al.Chromatin modifications remodel cardiac gene expression. Cardiovascular Research, 2014,103(1):7-16.
[54] Böhmdorfer G, Wierzbicki A T. Control of chromatin structure by long noncoding RNA. Trends in Cell Biology, 2015, 25(10):623-632.
[55] Bida O, Gidoni M, Ideses D, et al.A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget, 2015, 6(29):27880-27890.
[56] Singh R, Mo Y Y. LncRNA BC200 is induced by estradiol and regulates apoptosis in MCF-7 breast cancer cells. Cancer Research, 2015, 75(15 Supplement):156-156.
[57] Feng J, Funk W D, Wang S S, et al. The RNA component of human telomerase. Science. 1995, 269(5228):1236-1241.
[58] Yang L, Lin C, Liu W, et al. ncRNA-and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell, 2011, 147(4):773-788.
[59] Yang L, Lin C, Jin C, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature, 2013, 500(7464):598-602.
[60] Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329(5992):689-693.
[61] Martens J A, Laprade L, Winston F. Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature, 2004, 429(6991):571-574.
[62] Jiang W, Liu Y, Liu R, et al. The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression. Cell Reports, 2015, 11(1):137-148.
[63] Yang F, Deng X, Ma W, et al.The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation. Genome Biology, 2015, 16(1):1-17.
[64] Xiao T, Liu L, Li H, et al. Long Noncoding RNA ADINR Regulates Adipogenesis by Transcriptionally Activating C/EBPα. Stem Cell Reports, 2015, 5(5):856-865.
[65] Winter J, Jung S, Keller S, et al. Many roads to maturity:microRNA biogenesis pathways and their regulation. Nature Cell Biology, 2009, 11(3):228-234.
[66] Lauressergues D, Couzigou J M, San Clemente H, et al.Primary transcripts of microRNAs encode regulatory peptides. Nature, 2015,520(7545):1-15.
[67] Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell, 2015, 161(4):774-789.
[68] Yakovchuk P, Goodrich J A, Kugel J F. B2 RNA and Alu RNA repress transcription by disrupting contacts between RNA polymerase Ⅱ and promoter DNA within assembled complexes. Proceedings of the National Academy of Sciences, 2009, 106(14):5569-5574.
[69] Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 2007, 129(7):1311-1323.
[70] Goodrich J A, Kugel J F. Non-coding-RNA regulators of RNA polymerase Ⅱ transcription. Nature Reviews Molecular Cell Biology, 2006, 7(8):612-616.
[71] Watanabe T, Totoki Y, Toyoda A, et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature, 2008, 453(7194):539-543.
[72] Tam O H, Aravin A A, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature, 2008, 453(7194):534-538.
[73] Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?. Cell, 2011, 146(3):353-358.
[74] Paraskevopoulou M D, Georgakilas G, Kostoulas N, et al. DIANA-LncBase:experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Research, 2013, 41(D1):239-245.
[75] Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Research, 2010, 38(16):5366-5383.
[76] Wang K, Liu C Y, Zhou L Y, et al.APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nature Communications, 2015, 6(6779):1-11.
[77] Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell, 2011, 147(2):358-369.
[78] Wang Y, Pang W J, Wei N, et al. Identification, stability and expression of Sirt1 antisense long non-coding RNA. Gene, 2014, 539(1):117-124.
[79] Deng L, Yang S B, Xu F F, et al. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. Journal of Experimental & Clinical Cancer Research, 2015, 34(18):1-10.
[80] Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, 2011, 30(47):4750-4756.
[81] Wang K, Long B, Zhou L Y, et al.CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nature Communications, 2014, 5(3539):1-13.
[82] Tang Y, Jin X, Xiang Y, et al.The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT. FEBS Letters, 2015, 589(20):3189-3196.
[83] Lu L, Luo F, Liu Y, et al.Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract. Toxicology and Applied Pharmacology, 2015, 289(2):276-285.
[84] Hirata H, Hinoda Y, Shahryari V, et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Research, 2015, 75(7):1322-1331.
[85] Wang X, Li M, Wang Z, et al. Silencing of long noncoding rna malat1 by mir-101 and mir-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. Journal of Biological Chemistry, 2015, 290(7):3925-3935.
[86] Yan B, Yao J, Liu J Y, et al. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circulation Research, 2015, 116(7):1143-1156.
[87] Tsang F H, Au S L, Wei L, et al. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver International, 2015, 35(5):1597-1606.
[88] Gernapudi R, Wolfson B, Zhang Y, et al. miR-140 Promotes Expression of long non-coding RNA NEAT1 in Adipogenesis. Molecular and Cellular Biology, 2015,36(1):30-38.
[89] Wang P, Liu Y H, Yao Y l, et al. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cellular Signalling, 2015, 27(2):275-282.
[90] Cai H, Xue Y, Wang P, et al. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget, 2015, 6(23):19759-19779.
[91] Wang K, Liu F, Zhou L Y, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circulation Research, 2014, 114(9):1377-1388.
[92] Cai X, Hagedorn C H, Cullen B R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna, 2004, 10(12):1957-1966.
[93] Liz J, Portela A, Soler M, et al. Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Molecular Cell, 2014, 55(1):138-147.
[94] Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase Ⅱ. The EMBO Journal, 2004, 23(20):4051-4060.
[95] Aravin A A, Hannon G J, Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science, 2007, 318(5851):761-764.
[96] Wilusz J E, Freier S M, Spector D L. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell, 2008, 135(5):919-932.
[97] Ganesan G, Rao S M. A novel noncoding RNA processed by Drosha is restricted to nucleus in mouse. Rna, 2008, 14(7):1399-1410.
[98] Fejes-Toth K, Sotirova V, Sachidanandam R, et al. Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature, 2009, 457(7232):1028-1032.
[99] Wilusz J E, Sunwoo H, Spector D L. Long noncoding RNAs:functional surprises from the RNA world. Genes & Development, 2009, 23(13):1494-1504.
[100] Ogawa Y, Sun B K, Lee J T. Intersection of the RNA interference and X-inactivation pathways. Science, 2008, 320(5881):1336-1341.
[101] Xiao T, Liu L, Li H, et al. Long Noncoding RNA ADINR Regulates Adipogenesis by Transcriptionally Activating C/EBPα. Stem Cell Reports, 2015, 5(5):856-865.
[102] Yang F, Zhang L, Huo X S, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology, 2011, 54(5):1679-1689.
[103] Zhao X Y, Li S, Wang G X, et al. A long noncoding RNA transcriptional regulatory circuit drives thermogenic adipocyte differentiation. Molecular Cell, 2014, 55(3):372-382.
[104] Ⅱott N E, Heward J A, Roux B, et al.Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nature Communications, 2014, 5(3979):1-13.
[105] Yu Y, Fuscoe J C, Zhao C, et al.A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages. Nature Communications, 2014, 5(3230):1-11.
[106] Sun K, Zhao Y, Wang H, et al.Sebnif:An Integrated Bioinformatics Pipeline for the Identification of Novel Large Intergenic Noncoding RNAs (lincRNAs)-Application in Human Skeletal Muscle Cells. PloS one, 2014, 9(1):1-9.
[107] Divoux A, Karastergiou K, Xie H, et al. Identification of a novel lncRNA in gluteal adipose tissue and evidence for its positive effect on preadipocyte differentiation. Obesity, 2014, 22(8):1781-1785.
[108] Sun L, Goff L A, Trapnell C, et al. Long noncoding RNAs regulate adipogenesis. Proceedings of the National Academy of Sciences, 2013, 110(9):3387-3392.
[109] Li P, Ruan X, Yang L, et al. A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metabolism, 2015, 21(3):455-467.
[110] Leucci E, Patella F, Waage J, et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Scientific Reports, 2013, 3(2535):1-6.
[111] Imam H, Bano A S, Patel P, et al.The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins. Scientific Reports, 2015, 5(8639):1-10.
[112] Krol J, Krol I, Alvarez C P P, et al.A network comprising short and long noncoding RNAs and RNA helicase controls mouse retina architecture. Nature Communications, 2015, 6(7305):1-13.
[113] Spurlock Ⅲ C F, Tossberg J T, Guo Y, et al.Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nature Communications, 2015, 6(6932):1-12.
[114] White N M, Cabanski C R, Silva-Fisher J M, et al.Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol, 2014, 15(8):1-16.
[115] Iyer M K, Niknafs Y S, Malik R, et al.The landscape of long noncoding RNAs in the human transcriptome. Nature Genetics, 2015,doi:10.1038/ng.3192.
[116] Imamura K, Imamachi N, Akizuki G, et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Molecular Cell, 2014, 53(3):393-406.
[117] Yang F, Yi F, Han X, et al. MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Letters, 2013, 587(19):3175-3181.
[118] Lai M C, Yang Z, Zhou L, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Medical Oncology, 2012, 29(3):1810-1816.
[119] Liu J H, Chen G, Dang Y W, et al. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pacific journal of cancer prevention:APJCP, 2013, 15(7):2971-2977.
[120] Arase M, Horiguchi K, Ehata S, et al. Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC (A) cells. Cancer Science, 2014, 105(8):974-982.
[121] Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Letters, 2013, 333(2):213-221.
[122] Krawczyk M, Emerson B M. p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife, 2014, doi:org/10.7554/eLife.01776.001.
[123] Prensner J R, Mehra R, Chinnaiyan A M, et al.SChLAP1:a newly validated lncRNA biomarker for aggressive prostate cancer. RNA & DISEASE, 2015, 2(2):1-4.
[124] Mehra R, Shi Y, Udager A M, et al. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia, 2014, 16(12):1121-1127.
[125] Sahu A, Iyer M K, Prensner J R, et al. The role of long noncoding RNA SChLAP1 in prostate cancer. Cancer Research, 2014, 74(19 Supplement):541-541.
[126] Malik R, Patel L, Prensner J R, et al. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Molecular Cancer Research, 2014, 12(8):1081-1087.
[127] Chakravarty D, Sboner A, Nair S S, et al.The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature Communications, 2014, 5(5383):1-16.
[128] Prensner J R, Feng F Y C. The role of the PCAT-1 lncRNA in prostate cancer tumorigenesis. RNA & Disease, 2015, 2(1):900-908.
[129] Prensner J R, Chen W, Han S, et al. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia, 2014, 16(11):900-908.
[130] Zhu M, Chen Q, Liu X, et al. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS Journal, 2014, 281(16):3766-3775.
[131] Salameh A, Lee A K, Cardó-Vila M, et al. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proceedings of the National Academy of Sciences, 2015, 112(27):8403-8408.
[132] Li L, Dang Q, Xie H, et al.Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget, 2015, 6(16):14179-14190.
[133] Zhang A, Zhao J C, Kim J, et al. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Reports, 2015, 13(1):209-221.
[134] Liu Y, Zhang R, Qiu F, et al. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs:a case study in prostate cancer. Molecular Bio Systems, 2015, 11(2):384-393.
[135] Isin M, Uysaler E, Özgür E, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Frontiers in Genetics, 2015, 6(168):1-5.
[136] Wang L, Han S, Jin G, et al. Linc00963:A novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. International Journal of Oncology, 2014, 44(6):2041-2049.
[137] Richards E, Zhang G, Permuth-Wey J, et al. Identification of TGFβ-regulated long noncoding RNAs in mammary epithelia:lncRNA-HIT mediated TGFβ-induced EMT and breast cancer metastasis. Cancer Research, 2015, 75(15 Supplement):154-154.
[138] Feng FY, Ma T, Speers C, et al. Abstract PD6-1:The long noncoding RNA M41 promotes aggressiveness and tamoxifen resistance in ER-positive breast cancers. Cancer Research, 2015, 75(9):1-6.
[139] Xing Z, Park P K, Lin C, et al.LncRNA BCAR4 wires up signaling transduction in breast cancer. RNA Biology, 2015, 12(7):681-689.
[140] Shi Y, Li J, Liu Y, et al. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Molecular Cancer, 2015, 14(51):1-13
[141] Koirala P, Mo Y Y. LncRNA AK023948 promotes breast tumorigenesis by enhancing AKT phosphorylation. Cancer Research, 2015, 75(15 Supplement):155-155.
[142] Xue X, Yang Y, Zhang A, et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene, 2016,35(21):2746-2755.
[143] Zhou M, Hou Y, Yang G, et al. LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway. Stem Cells, 2015, 34(1):55-66.
[144] Shi S, Wang L, Yu B, et al.LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget, 2015, 6(13):11652-11663.
[145] Zhuang J, Lu Q, Shen B, et al.TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Scientific Reports, 2015, 5(11924):1-13.
[146] Fan Y, Shen B, Tan M, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS Journal, 2014, 281(7):1750-1758.
[147] Berrondo C, Flax J, Messing E M, et al. The long non-coding RNA HOTAIR affects exosome-mediated bladder cancer progression. Cancer Research, 2015, 75(15 Supplement):152-152.
[148] Li S, Yu Z, Li F, et al.The YAP1 Oncogene Contributes to Bladder Cancer Cell Proliferation and Migration by Regulating the H19 Long Noncoding RNA. In:Urologic Oncology:Seminars and Original Investigations; 2015:Elsevier, 2015, 33(427):1-10.
[149] Tan J, Qiu K, Li M, et al. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Letters, 2015, 589(20):3175-3181.
[150] Iguchi T, Uchi R, Nambara S, et al. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Research, 2015, 35(3):1385-1388.
[151] Zheng H T, Shi D B, Wang Y W, et al.High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. International Journal of Clinical and Experimental Pathology, 2014, 7(6):3174-3181.
[152] Ma Y, Yang Y, Wang F, et al.Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α. Gut, 2016,65(9):1494-1504.
[153] Shi D, Zheng H, Zhuo C, et al. Low expression of novel lncRNA RP11-462C24. 1 suggests a biomarker of poor prognosis in colorectal cancer. Medical Oncology, 2014, 31(7):1-9.
[154] Yin D, He X, Zhang E, et al. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Medical Oncology, 2014, 31(11):1-8.
[155] Yang Y, Li H, Hou S, et al.The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One, 2013, 5(8):1-12.
[156] Thai P, Statt S, Chen C H, et al. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. American Journal of Respiratory Cell and Molecular Biology, 2013, 49(2):204-211.
[157] Shi X, Sun M, Liu H, et al.A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Molecular Carcinogenesis, 2013, 54(1):1-12.
[158] Qiu M, Xu Y, Yang X, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biology, 2014, 35(6):5375-5380.
[159] Fan M, Li X, Jiang W, et al. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Experimental and Therapeutic Medicine, 2013, 5(4):1143-1146.
[160] Yang F, Bi J, Xue X, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS Journal, 2012, 279(17):3159-3165.
[161] Li H, Yu B, Li J, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget, 2014, 5(8):2318-2329.
[162] Sun W, Wu Y, Yu X, et al. Decreased expression of long noncoding RNA AC096655. 1-002 in gastric cancer and its clinical significance. Tumor Biology, 2013, 34(5):2697-2701.
[163] Sun M, Xia R, Jin F, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumor Biology, 2014, 35(2):1065-1073.
[164] Zhao Y, Guo Q, Chen J, et al. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer:a clinical and in vitro investigation. Oncology Reports, 2014, 31(1):358-364.
[165] Kim K, Jutooru I, Chadalapaka G, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene, 2013, 32(13):1616-1625.
[166] Ma C, Nong K, Zhu H, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumor Biology, 2014, 35(9):9163-9169.
[167] Wang Y, He L, Du Y, et al. The Long Noncoding RNA lncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling. Cell Stem Cell, 2015, 16(4):413-425.
[168] Tsang F H, Au S L, Wei L, et al. HOTTIP, an oncogenic long non-coding RNA, is frequently up-regulated in hepatocellular carcinoma and is negatively regulated by tumor suppressive microRNA miR-125b. Cancer Research, 2015, 75(15 Supplement):145-145. |
